Search
for
Sort by
Research 61–90 of 517
- Moving Beyond Boundaries: Utilization of Longitudinal Exposure–Response Model for Bounded Outcome Score to Inform Decision Making in the Accelerated Drug Development Paradigm
- Emerging Topics in Cardiometabolic and Psychologic Sequelae, Pathogenesis, and Treatment of Polycystic Ovarian Syndrome: A Review
- Epidemiological Assessment of Testosterone Levels in Women Population: A Factorial Analysis of Cell Proliferation
- Sexual dimorphism of COVID-19 inspires drug repositioning and host-targeting immunotherapy for viral pneumonia
- An Unusual Case of Elevated Testosterone: When Testosterone by Dialysis Saves the Day
- Gender-linked differences in human skin
- Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
- Polycystic ovary syndrome
- Endocrine Treatment of Transsexual Persons:An Endocrine Society Clinical Practice Guideline
- ACOG Practice Bulletin No. 108: Polycystic Ovary Syndrome
- Androgen Therapy in Women: An Endocrine Society Clinical Practice Guideline
- Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
- Androgen Receptor Antagonists (Antiandrogens) Structure-Activity Relationships
- Sex differences in the hypothalamic–pituitary–adrenal axis’ response to stress: an important role for gonadal hormones
- Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis
- ATP-competitive mTOR kinase inhibitors delay plant growth by triggering early differentiation of meristematic cells but no developmental patterning change
- Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men
- Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria
- Androgen Dependence of Hirsutism, Acne, and Alopecia in Women
- Finasteride induced depression: a prospective study
- Polycystic Ovary Syndrome: Update on Diagnosis and Treatment
- Association of Suicidality and Depression With 5α-Reductase Inhibitors
- Polycystic Ovary Syndrome
- Safety of testosterone treatment in postmenopausal women
- Side-Effects of Spironolactone Therapy in the Hirsute Woman
- Genome-wide association study identifies a new locus JMJD1C at 10q21 that may influence serum androgen levels in men
- Diagnosis of hyperandrogenism: Biochemical criteria
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- Costunolide—A Bioactive Sesquiterpene Lactone with Diverse Therapeutic Potential
- Androgens and Female Sexual Function and Dysfunction—Findings From the Fourth International Consultation of Sexual Medicine